Boston Scientific Corp. BSX
$43.34
-0.48%
at last close
Financials (TTM)
- Revenue
- $21.00 billion
- Net Income
- $3.67 billion
- Net Margin
- 17.47%
- Return on Equity
- 14.58%
- Debt-to-Equity
- —
- P/E Ratio
- 17.55
- Price / Book
- 2.51
- Price / Sales
- 3.01
Over the trailing twelve months, Boston Scientific Corp. generated revenue of $21.00 billion and net income of $3.67 billion, a net margin of 17.47%.
At the last closing price of $43.34, BSX trades at 17.55 times trailing earnings and 3.01 times sales, with a market capitalization of $63.11 billion.
Key Stats
- Last Close
- $43.34
- Market Cap
- $63.11 billion
- 52-Week Range
- $42.20 – $109.50
- Average Volume
- 20.53 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.